Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
- PMID: 20595157
- DOI: 10.1183/09031936.00043710
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach
Abstract
The aim of our study was to estimate the case fatality of a severe exacerbation from long-term survival data presented in the literature. A literature search identified studies reporting ≥1.5 yr survival after a severe chronic obstructive pulmonary disease (COPD) exacerbation resulting in hospitalisation. The survival curve of each study was divided into a critical and a stable period. Mortality during the stable period was then estimated by extrapolating the survival curve during the stable period back to the time of exacerbation onset. Case fatality was defined as the excess mortality that results from an exacerbation and was calculated as 1 minus the (backwardly) extrapolated survival during the stable period at the time of exacerbation onset. The 95% confidence intervals (CI) of the estimated case fatalities were obtained by bootstrapping. A random effect model was used to combine all estimates into a weighted average with 95% CI. The meta-analysis based on six studies that fulfilled the inclusion criteria resulted in a weighted average case-fatality rate of 15.6% (95% CI 10.9-20.3), ranging from 11.4% to 19.0% for the individual studies. A severe COPD exacerbation requiring hospitalisation not only results in higher mortality risks during hospitalisation, but also in the time-period after discharge and contributes substantially to total COPD mortality.
Similar articles
-
Recent improvement in long-term survival after a COPD hospitalisation.Thorax. 2010 Apr;65(4):298-302. doi: 10.1136/thx.2009.124818. Thorax. 2010. PMID: 20388752
-
Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.Am J Emerg Med. 2007 Jun;25(5):515-22. doi: 10.1016/j.ajem.2006.09.014. Am J Emerg Med. 2007. PMID: 17543654
-
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004. Clin Ther. 2008. PMID: 18803985
-
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.Thorax. 2008 Feb;63(2):122-8. doi: 10.1136/thx.2007.082636. Epub 2007 Aug 16. Thorax. 2008. PMID: 17702790 Review.
-
The prognostic variables predictive of mortality in patients with an exacerbation of COPD admitted to the ICU: an integrative review.QJM. 2012 Feb;105(2):115-26. doi: 10.1093/qjmed/hcr210. Epub 2011 Nov 8. QJM. 2012. PMID: 22071965 Review.
Cited by
-
Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.Pharmacoeconomics. 2012 Apr;30(4):271-302. doi: 10.2165/11589270-000000000-00000. Pharmacoeconomics. 2012. PMID: 22409290 Review.
-
What Are the Most Effective Factors in Determining Future Exacerbations, Morbidity Weight, and Mortality in Patients with COPD Attack?Medicina (Kaunas). 2022 Jan 21;58(2):163. doi: 10.3390/medicina58020163. Medicina (Kaunas). 2022. PMID: 35208487 Free PMC article.
-
Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations.Clin Med Insights Circ Respir Pulm Med. 2011;5:57-70. doi: 10.4137/CCRPM.S7049. Epub 2011 Oct 18. Clin Med Insights Circ Respir Pulm Med. 2011. PMID: 22084617 Free PMC article.
-
Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammation.PLoS One. 2014 Jun 11;9(2):e98440. doi: 10.1371/journal.pone.0098440. eCollection 2014. PLoS One. 2014. PMID: 24918427 Free PMC article.
-
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.Eur Respir J. 2023 Apr 1;61(4):2300239. doi: 10.1183/13993003.00239-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 36858443 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical